Tyrosine Kinase
Receptor tyrosine kinases bind to extracellular ligands/growth factors, which promotes receptor dimerization and autophosphorylation of receptor tyrosine residues. This triggers a cascade of downstream events through phosphorylation of intracellular proteins that ultimately transduce the extracellular signal to the nucleus, causing changes in gene expression. Receptor tyrosine kinases include EGFR/ErbB, PDGFR, VEGFR, FGFR and MET subfamilies etc. Dysfunctions in tyrosine phosphorylation are linked to oncogenic transformation. In additions, various adaptor and effector proteins couple to carboxy-terminal of an active kinase. For instance, binding of the GRB2 adaptor protein activates EGFR and MAPK/ERK signaling.
Non-receptor tyrosine kinases involve many well-defined proteins (e.g. the Src family kinases, c-Abl, and Jak kinases) and other kinases which regulates cell growth and differentiation. For example, Src family kinases are curial for activating and inhibitory pathways in the innate immune response.
- A8706 BLU9931Target: FGFRSummary: FGFR4 inhibitor,potent and irreversible
- B5843 CTX0294885Target: KinasesSummary: Pan-kinase inhibitor
- B6054 EAI045Summary: Inhibitor of L858R/T790M EGFR mutants
- A8197 Compound 561 CitationTarget: EGFRSummary: REGFR inhibitor
- A8199 PD153035 hydrochloride1 CitationTarget: EGFRSummary: Potent EGFR inhibitor
- A3009 Sorafenib2 CitationTarget: Raf|VEGFRSummary: Raf kinases and tyrosine kinases inhibitor
- A3014 BGJ3981 CitationTarget: FGFRSummary: FGFR inhibitor ,potent and selective
- A3017 Dasatinib (BMS-354825)4 CitationSummary: Src and BCR-Abl inhibitor
- A3020 (R)-Crizotinib2 CitationTarget: c-METSummary: C-MET/ALK inhibitor,potent and ATP-competitve
- A3022 Pazopanib (GW-786034)Target: CSF-1R|VEGFR|PDGFR|c-Kit|FGFRSummary: VEGFR/PDGFR/FGFR inhibitor